Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01319526 · ClinicalTrials.gov registry record
Biomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Undergoing Chemotherapy
A clinical trial, sponsored by AIDS Malignancy Consortium.
- Terminated
- Registry status
- 1
- Enrollment target
NCT01319526: Clinical Trial study, sponsored by AIDS Malignancy Consortium.
NCT01319526 is a clinical trial that was terminated before completion, run by AIDS Malignancy Consortium. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01319526 was terminated before completion, sponsored by AIDS Malignancy Consortium.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of blood in the laboratory from patients undergoing treatment with HIV infection and Hodgkin lymphoma may help doctors learn more about the effects of therapy on HIV. PURPOSE: This research study is studying biomarkers in blood samples from patients with HIV infection and stage III or stage IV Hodgkin lymphoma undergoing chemotherapy.
Primary Outcome
Time frame for outcome measures dependent on study calendar for parent protocol, S0816, which varies by subject's PET scan status.
Interventions
- OTHER laboratory biomarker analysis
- GENETIC DNA analysis
- GENETIC RNA analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2011-06 |
| Est. Completion | 2013-01 |
Why NCT01319526 stopped before completion
NCT01319526 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which laboratory biomarker analysis is the first listed.
NCT01319526 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01319526 about?
NCT01319526 is a clinical study titled "Biomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Undergoing Chemotherapy". RATIONALE: Studying samples of blood in the laboratory from patients undergoing treatment with HIV infection and Hodgkin lymphoma may help doctors learn more about the effects of therapy on HIV. PURPOSE: This research study is studying biomarkers in blood samples from patients with HIV infection an...
What is the current status of trial NCT01319526?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2011-06. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01319526?
The interventions under investigation include: laboratory biomarker analysis (OTHER), DNA analysis (GENETIC), RNA analysis (GENETIC).
Who is sponsoring clinical trial NCT01319526?
This trial is sponsored by AIDS Malignancy Consortium, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia